These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9918570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F, Müller W, Auberson YP, Tricklebank MD, Neijt HC.
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
    Schwabe K, Brosda J, Wegener N, Koch M.
    Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
    Bakshi VP, Swerdlow NR, Geyer MA.
    J Pharmacol Exp Ther; 1994 Nov; 271(2):787-94. PubMed ID: 7965797
    [Abstract] [Full Text] [Related]

  • 8. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
    Uehara T, Sumiyoshi T, Seo T, Matsuoka T, Itoh H, Suzuki M, Kurachi M.
    Brain Res; 2010 Sep 17; 1352():223-30. PubMed ID: 20633540
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
    Bakshi VP, Geyer MA.
    J Pharmacol Exp Ther; 1997 Nov 17; 283(2):666-74. PubMed ID: 9353384
    [Abstract] [Full Text] [Related]

  • 11. Endogenous kynurenic acid disrupts prepulse inhibition.
    Erhardt S, Schwieler L, Emanuelsson C, Geyer M.
    Biol Psychiatry; 2004 Aug 15; 56(4):255-60. PubMed ID: 15312813
    [Abstract] [Full Text] [Related]

  • 12. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats.
    Martinez ZA, Platten A, Pollack E, Shoemaker J, Ro H, Pitcher L, Geyer MA, Swerdlow NR.
    Psychopharmacology (Berl); 2002 Apr 15; 161(1):38-46. PubMed ID: 11967629
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
    Shilling PD, Feifel D.
    Psychopharmacology (Berl); 2002 Nov 15; 164(3):285-93. PubMed ID: 12424552
    [Abstract] [Full Text] [Related]

  • 15. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL, Wang RY.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1000-6. PubMed ID: 10215680
    [Abstract] [Full Text] [Related]

  • 16. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M, Zoli M, Mazzoncini R, Gennarelli M, Spano F.
    Psychopharmacology (Berl); 2001 Dec 15; 159(1):105-10. PubMed ID: 11797077
    [Abstract] [Full Text] [Related]

  • 17. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia.
    al-Amin HA, Schwarzkopf SB.
    Biol Psychiatry; 1996 Oct 15; 40(8):744-54. PubMed ID: 8894067
    [Abstract] [Full Text] [Related]

  • 18. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
    Bubeníková-Valesová V, Votava M, Pálenícek T, Horácek J.
    Neuropharmacology; 2007 Mar 15; 52(4):1071-8. PubMed ID: 17196227
    [Abstract] [Full Text] [Related]

  • 19. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
    Pietraszek M, Gravius A, Schäfer D, Weil T, Trifanova D, Danysz W.
    Neuropharmacology; 2005 Jul 15; 49(1):73-85. PubMed ID: 15992582
    [Abstract] [Full Text] [Related]

  • 20. The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    McAllister KH.
    Eur J Pharmacol; 1996 Oct 31; 314(3):307-11. PubMed ID: 8957251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.